ampyra

Acorda Therapeutics Announces Filing of Patent Extension Applications for AMPYRA(TM) (dalfampridine)

HAWTHORNE, N.Y., Mar 22, 2010 (BUSINESS WIRE) — Acorda Therapeutics, Inc. (ACOR 34.95, +0.11, +0.32%)today announced that the Company has submitted applications to…